SCHEMBL21615064

SCHEMBL21615064

c1ccc(-c2ccc(Nc3ccccc3-c3cccc4c3sc3ccccc34)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP14 Q460N5 1/20 0.54
▸ ALOX5 P09917 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MAP3K8 P41279 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CDC25B P30305 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15137702 0.96 ALOX5 (0.51) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL20317137 0.93 ALOX5 (0.50) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL15213984 0.92 ALOX5 (0.51) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL15137701 0.89 PARP14 (0.47) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL23690157 0.88 KDM4E (0.46) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL15138713 0.88 KDM4E (0.46) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL30746697 0.88 KDM4E (0.46) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL15773283 0.87 ALOX5 (0.55) PARP14ALOX5TDP1MAP3K8ALDH1A1
SCHEMBL22136358 0.87 ALOX5 (0.53) PARP14ALOX5KDM4EMEN1GLA
SCHEMBL15681384 0.86 ALOX5 (0.47) PARP14ALOX5KDM4EMEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2022-04-28 — — US disclosed
EP-3322693-B1 A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2020-02-12 — — EP disclosed
WO-2020007770-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MERCK PATENT GMBH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127251-A1 PROCESS FOR THE PRODUCTION OF ARYLAMINES MAOB, TYR, INMT PARP14 987/4885ALOX5 3383/4885KDM4E 941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback